Finally, as is the case for all molecular markers, it will be essential to rigorously examine the sensitivity and specificity of AH GDF15 given that serum GDF15 has been reported as a molecular marker for other systemic diseases, including cardiovascular diseases, obesity, kidney diseases, and diabetes. This evidence concerns the gene GDF15 and cardiovascular disorder.